Guy cable design and damping for vertical axis wind turbines

Guy cables are frequently used to support vertical axis wind turbines since guying the turbine reduces some of the structural requirements on the tower. The guys must be designed to provide both the required strength and the required stiffness at the top of the turbine. The axial load which the guys apply to the tower, bearings, and foundations is an undesirable consequence of using guys to support the turbine. Limiting the axial load so that it does not significantly affect the cost of the turbine is an important objective of the cable design. The lateral vibrations of the cables is another feature of the cable design which needs to be considered. These aspects of the cable design are discussed, and a technique for damping cable vibrations was mathematically analyzed and demonstrated with experimental data

Vertical axis wind turbine drive train transient dynamics

Start up of a vertical axis wind turbine causes transient torque oscillations in the drive train with peak torques which may be over two and one half times the rated torque of the turbine. A computer code, based on a lumped parameter model of the drive train, was developed and tested for the low cost 17 meter turbine; the results show excellent agreement with field data. The code was used to predict the effect of a slip clutch on transient torque oscillations. It was demonstrated that a slip clutch located between the motor and brake can reduce peak torques by thirty eight percent

Health monitoring of operational structures -- Initial results

Two techniques for damage localization (Structural Translational and Rotational Error Checking -- STRECH and MAtriX COmpletioN -- MAXCON) are described and applied to operational structures. The structures include a Horizontal Axis Wind Turbine (HAWT) blade undergoing a fatigue test and a highway bridge undergoing an induced damage test. STRECH is seen to provide a global damage indicator to assess the global damage state of a structure. STRECH is also seen to provide damage localization for static flexibility shapes or the first mode of simple structures. MAXCON is a robust damage localization tool using the higher order dynamics of a structure. Several options arc available to allow the procedure to be tailored to a variety of structures

Structural dynamics modeling and testing of the Department of Energy tractor/trailer combination

This study presents a combined analytical and experimental effort to characterize and improve the ride quality of the Department of Energy tractor/trailer combination. The focus is to augment the experimental test results with the use of a high quality computer model. The discussion includes an overview of the finite element model of the vehicle and experimental modal test results. System identification techniques are employed to update the mathematical model. The validated model is then used to illustrate the benefits of incorporating two major design changes, namely the switch from a separate cab/sleeper configuration to an integrated cab, and the use of a cab suspension system

INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer

BACKGROUND: Whilst multi-parametric magnetic resonance imaging (mp-MRI) has been a significant advance in the diagnosis of prostate cancer, scanning all patients with elevated prostate specific antigen (PSA) levels is considered too costly for widespread National Health Service (NHS) use, as the predictive value of PSA levels for significant disease is poor. Despite the fact that novel blood and urine tests are available which may predict aggressive disease better than PSA, they are not routinely employed due to a lack of clinical validity studies. Furthermore approximately 40% of mp-MRI studies are reported as indeterminate, which can lead to repeat examinations or unnecessary biopsy with associated patient anxiety, discomfort, risk and additional costs. METHODS AND ANALYSIS: We aim to clinically validate a panel of minimally invasive promising blood and urine biomarkers, to better select patients that will benefit from a multiparametric prostate MRI. We will then test whether the performance of the mp-MRI can be improved by the addition of an advanced diffusion-weighted MRI technique, which uses a biophysical model to characterise tissue microstructure called VERDICT; Vascular and Extracellular Restricted Diffusion for Cytometry in Tumours. INNOVATE is a prospective single centre cohort study in 365 patients. mpMRI will act as the reference standard for the biomarker panel. A clinical outcome based reference standard based on biopsy, mp-MRI and follow-up will be used for VERDICT MRI. We expect the combined effect of biomarkers and VERDICT MRI will improve care by better detecting aggressive prostate cancer early and make mp-MRI before biopsy economically viable for universal NHS adoption. ETHICS AND DISSEMINATION: INNOVATE received UK Research Ethics Committee approval on 23rd December 2015 by the NRES Committee London—Surrey Borders with REC reference 15/LO/0692. REGISTRATION DETAILS: INNOVATE is registered on ClinicalTrials.gov, with reference NCT0268927

Approximations of Shape Metrics and Application to Shape Warping and Empirical Shape Statistics

International audienceThis chapter proposes a framework for dealing with two problems related to the analysis of shapes: the definition of the relevant set of shapes and that of defining a metric on it. Following a recent research monograph by Delfour and Zolésio [8], we consider the characteristic functions of the subsets of ℝ2 and their distance functions. The L 2 norm of the difference of characteristic functions and the L∞ and the W 1,2 norms of the difference of distance functions define interesting topologies, in particular that induced by the well-known Hausdorff distance. Because of practical considerations arising from the fact that we deal with image shapes defined on finite grids of pixels, we restrict our attention to subsets of ℝ2 of positive reach in the sense of Federer [12], with smooth boundaries of bounded curvature. For this particular set of shapes we show that the three previous topologies are equivalent. The next problem we consider is that of warping a shape onto another by infinitesimal gradient descent, minimizing the corresponding distance. Because the distance function involves an inf, it is not differentiable with respect to the shape. We propose a family of smooth approximations of the distance function which are continuous with respect to the Hausdorff topology, and hence with respect to the other two topologies. We compute the corresponding Gâteaux derivatives. They define deformation flows that can be used to warp a shape onto another by solving an initial value problem. We show several examples of this warping and prove properties of our approximations that relate to the existence of local minima. We then use this tool to produce computational de.nitions of the empirical mean and covariance of a set of shape examples. They yield an analog of the notion of principal modes of variation. We illustrate them on a variety of examples

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial

OBJECTIVES: To assess the clinical outcomes of mpMRI before biopsy and evaluate the space remaining for novel biomarkers. METHODS: The INNOVATE study was set up to evaluate the validity of novel fluidic biomarkers in men with suspected prostate cancer who undergo pre-biopsy mpMRI. We report the characteristics of this clinical cohort, the distribution of clinical serum biomarkers, PSA and PSA density (PSAD), and compare the mpMRI Likert scoring system to the Prostate Imaging–Reporting and Data System v2.1 (PI-RADS) in men undergoing biopsy. RESULTS: 340 men underwent mpMRI to evaluate suspected prostate cancer. 193/340 (57%) men had subsequent MRI-targeted prostate biopsy. Clinically significant prostate cancer (csigPCa), i.e., overall Gleason ≥ 3 + 4 of any length OR maximum cancer core length (MCCL) ≥4 mm of any grade including any 3 + 3, was found in 96/195 (49%) of biopsied patients. Median PSA (and PSAD) was 4.7 (0.20), 8.0 (0.17), and 9.7 (0.31) ng/mL (ng/mL/mL) in mpMRI scored Likert 3,4,5 respectively for men with csigPCa on biopsy. The space for novel biomarkers was shown to be within the group of men with mpMRI scored Likert3 (178/340) and 4 (70/350), in whom an additional of 40% (70/178) men with mpMRI-scored Likert3, and 37% (26/70) Likert4 could have been spared biopsy. PSAD is already considered clinically in this cohort to risk stratify patients for biopsy, despite this 67% (55/82) of men with mpMRI-scored Likert3, and 55% (36/65) Likert4, who underwent prostate biopsy had a PSAD below a clinical threshold of 0.15 (or 0.12 for men aged <50 years). Different thresholds of PSA and PSAD were assessed in mpMRI-scored Likert4 to predict csigPCa on biopsy, to achieve false negative levels of ≤5% the proportion of patients whom who test as above the threshold were unsuitably high at 86 and 92% of patients for PSAD and PSA respectively. When PSA was re tested in a sub cohort of men repeated PSAD showed its poor reproducibility with 43% (41/95) of patients being reclassified. After PI-RADS rescoring of the biopsied lesions, 66% (54/82) of the Likert3 lesions received a different PI-RADS score. CONCLUSIONS: The addition of simple biochemical and radiological markers (Likert and PSAD) facilitate the streamlining of the mpMRI-diagnostic pathway for suspected prostate cancer but there remains scope for improvement, in the introduction of novel biomarkers for risk assessment in Likert3 and 4 patients, future application of novel biomarkers tested in a Likert cohort would also require re-optimization around Likert3/PI-RADS2, as well as reproducibility testing

Proteomic Analysis of Aortae from Human Lipoprotein(a) Transgenic Mice Shows an Early Metabolic Response Independent of Atherosclerosis

Background: Elevated low density lipoprotein (LDL) and lipoprotein(a) are independent risk factors for the development of atherosclerosis. Using a proteomic approach we aimed to determine early changes in arterial protein expression in transgenic mice containing both human LDL and lipoprotein(a) in circulation. Methods and Results: Plasma lipid analyses showed the lipoprotein(a) transgenic mice had significantly higher lipid levels than wildtype, including a much increased LDL and high density lipoprotein (HDL) cholesterol. Analysis of aortae from lipoprotein(a) mice showed lipoprotein(a) accumulation but no lipid accumulation or foam cells, leaving the arteries essentially atherosclerosis free. Using two-dimensional gel electrophoresis and mass spectrometry, we identified 34 arterial proteins with significantly altered abundance (P,0.05) in lipoprotein(a) transgenic mice compared to wildtype including 17 that showed a $2 fold difference. Some proteins of interest showed a similarly altered abundance at the transcript level. These changes collectively indicated an initial metabolic response that included a down regulation in energy, redox and lipid metabolism proteins and changes in structural proteins at a stage when atherosclerosis had not yet developed. Conclusions: Our study shows that human LDL and lipoprotein(a) promote changes in the expression of a unique set o

Repair of Parastomal Hernias with Biologic Grafts: A Systematic Review

Contains fulltext : 98303.pdf (publisher's version ) (Open Access)BACKGROUND: Biologic grafts are increasingly used instead of synthetic mesh for parastomal hernia repair due to concerns of synthetic mesh-related complications. This systematic review was designed to evaluate the use of these collagen-based scaffolds for the repair of parastomal hernias. METHODS: Studies were retrieved after searching the electronic databases MEDLINE, EMBASE and Cochrane CENTRAL. The search terms 'paracolostomy', 'paraileostomy', 'parastomal', 'colostomy', 'ileostomy', 'hernia', 'defect', 'closure', 'repair' and 'reconstruction' were used. Selection of studies and assessment of methodological quality were performed with a modified MINORS index. All reports on repair of parastomal hernias using a collagen-based biologic scaffold to reinforce or bridge the defect were included. Outcomes were recurrence rate, mortality and morbidity. RESULTS: Four retrospective studies with a combined enrolment of 57 patients were included. Recurrence occurred in 15.7% (95% confidence interval [CI] 7.8-25.9) of patients and wound-related complications in 26.2% (95% CI 14.7-39.5). No mortality or graft infections were reported. CONCLUSIONS: The use of reinforcing or bridging biologic grafts during parastomal hernia repair results in acceptable rates of recurrence and complications. However, given the similar rates of recurrence and complications achieved using synthetic mesh in this scenario, the evidence does not support use of biologic grafts